Lexicon Pharmaceuticals LXRX Operating Lease Liability - Undiscounted Excess Amount
Operating Lease Liability - Undiscounted Excess Amount at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's operating lease liability - undiscounted excess amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's operating lease liability - undiscounted excess amount?
- Lexicon Pharmaceuticals (LXRX) reported operating lease liability - undiscounted excess amount of $3.2M in Q1 2026.
- How has Lexicon Pharmaceuticals's operating lease liability - undiscounted excess amount changed year-over-year?
- Lexicon Pharmaceuticals's operating lease liability - undiscounted excess amount increased by 18.5% year-over-year, from $2.7M to $3.2M.
- What does operating lease liability - undiscounted excess amount mean?
- This represents the difference between the total undiscounted future lease payments and the present value of those payments recorded on the balance sheet. It effectively quantifies the interest component embedded within operating lease obligations. It is a measure of the financing cost inherent in the lease portfolio.